These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 25781943)

  • 1. Improving reconstituted HDL composition for efficient post-ischemic reduction of ischemia reperfusion injury.
    Brulhart-Meynet MC; Braunersreuther V; Brinck J; Montecucco F; Prost JC; Thomas A; Galan K; Pelli G; Pedretti S; Vuilleumier N; Mach F; Lecour S; James RW; Frias MA
    PLoS One; 2015; 10(3):e0119664. PubMed ID: 25781943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Native and reconstituted HDL activate Stat3 in ventricular cardiomyocytes via ERK1/2: role of sphingosine-1-phosphate.
    Frias MA; James RW; Gerber-Wicht C; Lang U
    Cardiovasc Res; 2009 May; 82(2):313-23. PubMed ID: 19151362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor.
    Theilmeier G; Schmidt C; Herrmann J; Keul P; Schäfers M; Herrgott I; Mersmann J; Larmann J; Hermann S; Stypmann J; Schober O; Hildebrand R; Schulz R; Heusch G; Haude M; von Wnuck Lipinski K; Herzog C; Schmitz M; Erbel R; Chun J; Levkau B
    Circulation; 2006 Sep; 114(13):1403-9. PubMed ID: 16982942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newly developed reconstituted high-density lipoprotein containing sphingosine-1-phosphate induces endothelial tube formation.
    Matsuo Y; Miura S; Kawamura A; Uehara Y; Rye KA; Saku K
    Atherosclerosis; 2007 Sep; 194(1):159-68. PubMed ID: 17118370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interplay between SAFE and RISK pathways in sphingosine-1-phosphate-induced cardioprotection.
    Somers SJ; Frias M; Lacerda L; Opie LH; Lecour S
    Cardiovasc Drugs Ther; 2012 Jun; 26(3):227-37. PubMed ID: 22392184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Native and reconstituted HDL protect cardiomyocytes from doxorubicin-induced apoptosis.
    Frias MA; Lang U; Gerber-Wicht C; James RW
    Cardiovasc Res; 2010 Jan; 85(1):118-26. PubMed ID: 19700468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-density lipoprotein determines adult mouse cardiomyocyte fate after hypoxia-reoxygenation through lipoprotein-associated sphingosine 1-phosphate.
    Tao R; Hoover HE; Honbo N; Kalinowski M; Alano CC; Karliner JS; Raffai R
    Am J Physiol Heart Circ Physiol; 2010 Mar; 298(3):H1022-8. PubMed ID: 20061542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sphingosine-1-phosphate reduces ischaemia-reperfusion injury by phosphorylating the gap junction protein Connexin43.
    Morel S; Christoffersen C; Axelsen LN; Montecucco F; Rochemont V; Frias MA; Mach F; James RW; Naus CC; Chanson M; Lampe PD; Nielsen MS; Nielsen LB; Kwak BR
    Cardiovasc Res; 2016 Mar; 109(3):385-96. PubMed ID: 26762268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sphingosine 1-phosphate S1P2 and S1P3 receptor-mediated Akt activation protects against in vivo myocardial ischemia-reperfusion injury.
    Means CK; Xiao CY; Li Z; Zhang T; Omens JH; Ishii I; Chun J; Brown JH
    Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2944-51. PubMed ID: 17293497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HDL and sphingosine-1-phosphate activate stat3 in prostate cancer DU145 cells via ERK1/2 and S1P receptors, and promote cell migration and invasion.
    Sekine Y; Suzuki K; Remaley AT
    Prostate; 2011 May; 71(7):690-9. PubMed ID: 20979115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The natural cardioprotective particle HDL modulates connexin43 gap junction channels.
    Morel S; Frias MA; Rosker C; James RW; Rohr S; Kwak BR
    Cardiovasc Res; 2012 Jan; 93(1):41-9. PubMed ID: 21960685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous sphingosylphosphorylcholine protects ischemic and postischemic myocardial tissue in a mouse model of myocardial ischemia/reperfusion injury.
    Herzog C; Schmitz M; Levkau B; Herrgott I; Mersmann J; Larmann J; Johanning K; Winterhalter M; Chun J; Müller FU; Echtermeyer F; Hildebrand R; Theilmeier G
    Mediators Inflamm; 2010; 2010():425191. PubMed ID: 21274265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes Mellitus Is Associated With Reduced High-Density Lipoprotein Sphingosine-1-Phosphate Content and Impaired High-Density Lipoprotein Cardiac Cell Protection.
    Brinck JW; Thomas A; Lauer E; Jornayvaz FR; Brulhart-Meynet MC; Prost JC; Pataky Z; Löfgren P; Hoffstedt J; Eriksson M; Pramfalk C; Morel S; Kwak BR; van Eck M; James RW; Frias MA
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):817-24. PubMed ID: 26966278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiarrhythmogenic effect of reconstituted high-density lipoprotein against ischemia/reperfusion in rats.
    Imaizumi S; Miura S; Nakamura K; Kiya Y; Uehara Y; Zhang B; Matsuo Y; Urata H; Ideishi M; Rye KA; Sata M; Saku K
    J Am Coll Cardiol; 2008 Apr; 51(16):1604-12. PubMed ID: 18420105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HDL-associated ApoM is anti-apoptotic by delivering sphingosine 1-phosphate to S1P1 & S1P3 receptors on vascular endothelium.
    Ruiz M; Okada H; Dahlbäck B
    Lipids Health Dis; 2017 Feb; 16(1):36. PubMed ID: 28179022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reconstituted HDL-apoE3 promotes endothelial cell migration through ID1 and its downstream kinases ERK1/2, AKT and p38 MAPK.
    Valanti EK; Dalakoura-Karagkouni K; Fotakis P; Vafiadaki E; Mantzoros CS; Chroni A; Zannis V; Kardassis D; Sanoudou D
    Metabolism; 2022 Feb; 127():154954. PubMed ID: 34875308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HDL protects against ischemia reperfusion injury by preserving mitochondrial integrity.
    Frias MA; Pedretti S; Hacking D; Somers S; Lacerda L; Opie LH; James RW; Lecour S
    Atherosclerosis; 2013 May; 228(1):110-6. PubMed ID: 23497785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of sphingosine-1-phosphate receptor agonist treatment after myocardial ischaemia-reperfusion.
    Hofmann U; Burkard N; Vogt C; Thoma A; Frantz S; Ertl G; Ritter O; Bonz A
    Cardiovasc Res; 2009 Jul; 83(2):285-93. PubMed ID: 19416991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-density lipoprotein-associated sphingosine-1-phosphate activity in heterozygous familial hypercholesterolaemia.
    Frias MA; Thomas A; Brulhart-Meynet MC; Kövamees O; Pernow J; Eriksson M; Angelin B; James RW; Brinck JW
    Eur J Clin Invest; 2017 Jan; 47(1):38-43. PubMed ID: 27861771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sphingosine protects aging hearts from ischemia/reperfusion injury: Superiority to sphingosine 1-phosphate and ischemic pre- and post-conditioning.
    Vessey DA; Kelley M; Li L; Huang Y
    Oxid Med Cell Longev; 2009; 2(3):146-51. PubMed ID: 20592769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.